All In Biotech

Free tool

FAERS Monitor: Topamax

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020505 or its brand name (Topamax, Topiramate). Reports on generic versions are filed under their own applications.

Reports

92,148

Serious

64,116

70% of reports

Hospitalization

23,994

Death reported

7,028

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective10,548
  • off label use7,681
  • headache6,623
  • nausea6,046
  • fatigue5,536
  • pain4,701
  • migraine4,500
  • dizziness4,290
  • seizure3,887
  • diarrhoea3,826
  • vomiting3,773
  • depression3,718
  • product use in unapproved indication3,361
  • weight increased3,140
  • condition aggravated3,055

Reports by year received

View as table
YearReports
20041,032
20051,462
20061,578
20071,391
20081,612
20092,237
20102,824
20113,117
20123,489
20133,185
20143,698
20155,908
20166,576
20175,198
20186,041
20196,491
20205,713
20215,342
20225,096
20235,154
20245,748
20255,583
20263,668

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,962,011 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
migraineSignal4,50011.210.940,184
seizureSignal3,8877.97.722,806
depressionSignal3,7183.83.77,540
weight increasedSignal3,1403.23.14,820
product use in unapproved indicationSignal3,3613.13.04,843
headacheSignal6,6232.42.45,661
condition aggravatedSignal3,0552.32.22,270
off label useSignal7,6812.02.04,037
dizziness4,2902.01.92,085
vomiting3,7731.81.81,463
drug ineffective10,5481.81.84,229
pain4,7011.81.71,552
nausea6,0461.71.72,000
fatigue5,5361.61.61,380
diarrhoea3,8261.41.3365

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.